{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3747, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "kpi_overview", "function": "summarize", "notes": "The slide uses a 2x2 grid layout to present key performance indicators.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/9", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-9", "loopMatches": [ { "to": 14, "from": 5, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "f381209b-40fa-4c32-8920-66d6dea883b8", "evidence": "Discussion of innovation horizons and market opportunities", "position": 0, "objective": "Why now is the time for argenx SE's innovation", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.7, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "10300344-3ff1-4b97-95a5-8662d641a2aa", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "Highlighting commercial execution and market opportunities", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "key_messages", "function": "size_opportunity", "notes": "The slide uses a stacked bar/arrow hybrid to illustrate growth. The data points are 6,000 (US patients), 17,000 (RoW TAM), and 31,000 (US TAM).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/10", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-10", "loopMatches": [ { "to": 14, "from": 5, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "f381209b-40fa-4c32-8920-66d6dea883b8", "evidence": "Discussion of innovation horizons and market opportunities", "position": 0, "objective": "Why now is the time for argenx SE's innovation", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.7, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "10300344-3ff1-4b97-95a5-8662d641a2aa", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "Highlighting commercial execution and market opportunities", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a two-stage framework to present clinical data and patient outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/11", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-11", "loopMatches": [ { "to": 14, "from": 5, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "f381209b-40fa-4c32-8920-66d6dea883b8", "evidence": "Discussion of innovation horizons and market opportunities", "position": 0, "objective": "Why now is the time for argenx SE's innovation", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.7, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "10300344-3ff1-4b97-95a5-8662d641a2aa", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "Highlighting commercial execution and market opportunities", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "Uses a visual metaphor of a patient partially submerged to represent 'unseen suffering'.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/12", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-12", "loopMatches": [ { "to": 14, "from": 5, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "f381209b-40fa-4c32-8920-66d6dea883b8", "evidence": "Discussion of innovation horizons and market opportunities", "position": 0, "objective": "Why now is the time for argenx SE's innovation", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.7, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "10300344-3ff1-4b97-95a5-8662d641a2aa", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "Highlighting commercial execution and market opportunities", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide highlights the progression of delivery technology enabled by the ENHANZE license.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/13", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-13", "loopMatches": [ { "to": 14, "from": 5, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "f381209b-40fa-4c32-8920-66d6dea883b8", "evidence": "Discussion of innovation horizons and market opportunities", "position": 0, "objective": "Why now is the time for argenx SE's innovation", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.7, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "10300344-3ff1-4b97-95a5-8662d641a2aa", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "Highlighting commercial execution and market opportunities", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "roadmap", "function": "plan_implementation", "notes": "Uses a pyramid-like growth visualization to represent expanding market opportunities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/14", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-14", "loopMatches": [ { "to": 14, "from": 5, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "f381209b-40fa-4c32-8920-66d6dea883b8", "evidence": "Discussion of innovation horizons and market opportunities", "position": 0, "objective": "Why now is the time for argenx SE's innovation", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.7, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "10300344-3ff1-4b97-95a5-8662d641a2aa", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "Highlighting commercial execution and market opportunities", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "comparison_table", "function": "quantify_opportunity", "notes": "The slide uses a matrix structure to compare clinical and commercial viability for three indications.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/15", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-15", "loopMatches": [ { "to": 20, "from": 15, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "febbca6c-7f97-4066-8898-43ab685a76f2", "evidence": "Pipeline horizon and potential for transformation", "position": 1, "objective": "Quick wins and big bets in pipeline development", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "9b26e95b-08d2-43e3-9516-c1a147c99880", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "The Breakthrough", "beatSlug": "rags-to-riches-the-breakthrough", "evidence": "Pipeline horizon and potential for transformation", "position": 3, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "roadmap", "function": "present_solution", "notes": "The slide uses a circular/arc layout to categorize assets into 'Immunology Innovation Program', 'Pipeline', and 'VYVGART Opportunity'.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/16", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-16", "loopMatches": [ { "to": 20, "from": 15, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "febbca6c-7f97-4066-8898-43ab685a76f2", "evidence": "Pipeline horizon and potential for transformation", "position": 1, "objective": "Quick wins and big bets in pipeline development", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "9b26e95b-08d2-43e3-9516-c1a147c99880", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "The Breakthrough", "beatSlug": "rags-to-riches-the-breakthrough", "evidence": "Pipeline horizon and potential for transformation", "position": 3, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses an infinity-loop style diagram to connect three key pillars of the drug's value proposition.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/17", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-17", "loopMatches": [ { "to": 20, "from": 15, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "febbca6c-7f97-4066-8898-43ab685a76f2", "evidence": "Pipeline horizon and potential for transformation", "position": 1, "objective": "Quick wins and big bets in pipeline development", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "9b26e95b-08d2-43e3-9516-c1a147c99880", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "The Breakthrough", "beatSlug": "rags-to-riches-the-breakthrough", "evidence": "Pipeline horizon and potential for transformation", "position": 3, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "key_takeaways", "function": "analyze_data", "notes": "Kaplan-Meier survival curve showing probability of being retreated with IVIg.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/18", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-18", "loopMatches": [ { "to": 20, "from": 15, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "febbca6c-7f97-4066-8898-43ab685a76f2", "evidence": "Pipeline horizon and potential for transformation", "position": 1, "objective": "Quick wins and big bets in pipeline development", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "9b26e95b-08d2-43e3-9516-c1a147c99880", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "The Breakthrough", "beatSlug": "rags-to-riches-the-breakthrough", "evidence": "Pipeline horizon and potential for transformation", "position": 3, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "testimonial", "function": "diagnose_problem", "notes": "The slide uses a central quote to humanize the clinical problem and market opportunity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/19", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-19", "loopMatches": [ { "to": 20, "from": 15, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "febbca6c-7f97-4066-8898-43ab685a76f2", "evidence": "Pipeline horizon and potential for transformation", "position": 1, "objective": "Quick wins and big bets in pipeline development", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "9b26e95b-08d2-43e3-9516-c1a147c99880", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "The Breakthrough", "beatSlug": "rags-to-riches-the-breakthrough", "evidence": "Pipeline horizon and potential for transformation", "position": 3, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "key_messages", "function": "present_solution", "notes": "The slide uses an infinity-loop style diagram to represent a continuous process or interconnected concepts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/20", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-20", "loopMatches": [ { "to": 20, "from": 15, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "febbca6c-7f97-4066-8898-43ab685a76f2", "evidence": "Pipeline horizon and potential for transformation", "position": 1, "objective": "Quick wins and big bets in pipeline development", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "9b26e95b-08d2-43e3-9516-c1a147c99880", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "The Breakthrough", "beatSlug": "rags-to-riches-the-breakthrough", "evidence": "Pipeline horizon and potential for transformation", "position": 3, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "other", "function": "analyze_data", "notes": "The slide uses two distinct scientific data visualizations: a longitudinal weight study in mice and a bar chart showing muscle contraction fidelity in an NMJ-on-a-chip model.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/21", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 21, "beatId": "4f520fa3-87c8-4ed1-a903-25e9788c3b4f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "Strong track record and growth potential", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "roadmap", "function": "present_framework", "notes": "The slide uses a circular/concentric layout to categorize assets into 'Immunology Innovation Program', 'Pipeline', and 'VYVGART Opportunity'.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/22", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 21, "beatId": "4f520fa3-87c8-4ed1-a903-25e9788c3b4f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "Strong track record and growth potential", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "key_messages", "function": "present_framework", "notes": "The diagram is a variation of a flywheel or infinity loop representing the integration of clinical development and disease insight.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/23", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 21, "beatId": "4f520fa3-87c8-4ed1-a903-25e9788c3b4f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "Strong track record and growth potential", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "roadmap", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/24", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 21, "beatId": "4f520fa3-87c8-4ed1-a903-25e9788c3b4f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "Strong track record and growth potential", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a bar chart to show growth and two tables for financial summaries.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/25", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 21, "beatId": "4f520fa3-87c8-4ed1-a903-25e9788c3b4f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "Strong track record and growth potential", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/26", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 21, "beatId": "4f520fa3-87c8-4ed1-a903-25e9788c3b4f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "Strong track record and growth potential", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "closing_ask", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/27", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/YlOfZB_Kb8wZXrUzUaBCCOT6HAxoDhgHBeJXVMBXOFE/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wMjM5YTcxZjljNjk0MjEwOTI2MDRhMGE2OTRmZGIwOS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/1", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "a3d58731-83e1-4ddb-b582-096537eae6e8", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Humble Origins", "beatSlug": "rags-to-riches-humble-origins", "evidence": "The deck starts with an overview of AstraZeneca as a global, science-led biopharmaceutical company.", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/kuSeTqEp8xsgOqgPAHkt4snwjlOlJO_jY1fPUg526oo/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wMjM5YTcxZjljNjk0MjEwOTI2MDRhMGE2OTRmZGIwOS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/wzv90V2l4GM31MVJxmaMB6q6auxdRkydavxfAKEjLbQ/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wMjM5YTcxZjljNjk0MjEwOTI2MDRhMGE2OTRmZGIwOS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/CCALsosMdlf-SVK5cgCWS2sjQAOFN1jWQYNEZhUcQu8/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wMjM5YTcxZjljNjk0MjEwOTI2MDRhMGE2OTRmZGIwOS9wMDAxLnBuZw" }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/2", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "a3d58731-83e1-4ddb-b582-096537eae6e8", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Humble Origins", "beatSlug": "rags-to-riches-humble-origins", "evidence": "The deck starts with an overview of AstraZeneca as a global, science-led biopharmaceutical company.", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a combination of big numbers, process diagrams for strategy, and a mix of donut and bar charts for revenue analysis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/3", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "a3d58731-83e1-4ddb-b582-096537eae6e8", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Humble Origins", "beatSlug": "rags-to-riches-humble-origins", "evidence": "The deck starts with an overview of AstraZeneca as a global, science-led biopharmaceutical company.", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a horizontal layout to segment the business into five pillars, each with specific growth drivers and outlooks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/4", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-4", "loopMatches": [ { "to": 9, "from": 4, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "4e7501eb-74e6-4ae7-8a18-04c13b6f5ddc", "evidence": "The deck outlines AstraZeneca's growth strategy and supporting data.", "position": 0, "objective": "How AstraZeneca's growth strategy will drive growth through 2030", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "89e38b66-4827-4196-94f1-792b29dc13ee", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Early Struggles", "beatSlug": "rags-to-riches-early-struggles", "evidence": "The deck highlights AstraZeneca's growth challenges and opportunities.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "key_takeaways", "function": "summarize", "notes": "The right-hand side is a complex matrix mapping clinical trials to patient segments (HER2-positive, HR-positive, TNBC, gBRCAm) and treatment stages (Neoadjuvant, Adjuvant, Metastatic).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/5", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-5", "loopMatches": [ { "to": 9, "from": 4, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "4e7501eb-74e6-4ae7-8a18-04c13b6f5ddc", "evidence": "The deck outlines AstraZeneca's growth strategy and supporting data.", "position": 0, "objective": "How AstraZeneca's growth strategy will drive growth through 2030", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "89e38b66-4827-4196-94f1-792b29dc13ee", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Early Struggles", "beatSlug": "rags-to-riches-early-struggles", "evidence": "The deck highlights AstraZeneca's growth challenges and opportunities.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "other", "function": "summarize", "notes": "The slide uses a structured grid to map corporate acquisitions/partnerships to strategic goals and therapeutic areas.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/6", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-6", "loopMatches": [ { "to": 9, "from": 4, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "4e7501eb-74e6-4ae7-8a18-04c13b6f5ddc", "evidence": "The deck outlines AstraZeneca's growth strategy and supporting data.", "position": 0, "objective": "How AstraZeneca's growth strategy will drive growth through 2030", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "89e38b66-4827-4196-94f1-792b29dc13ee", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Early Struggles", "beatSlug": "rags-to-riches-early-struggles", "evidence": "The deck highlights AstraZeneca's growth challenges and opportunities.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/7", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-7", "loopMatches": [ { "to": 9, "from": 4, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "4e7501eb-74e6-4ae7-8a18-04c13b6f5ddc", "evidence": "The deck outlines AstraZeneca's growth strategy and supporting data.", "position": 0, "objective": "How AstraZeneca's growth strategy will drive growth through 2030", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "aadac6c5-85ff-4c00-8a67-6ccfa3236c41", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "The deck showcases AstraZeneca's successes in various disease areas, including oncology and rare disease.", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a structured layout to present the company's oncology portfolio, categorizing drugs by their therapeutic focus and market position.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/8", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-8", "loopMatches": [ { "to": 9, "from": 4, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "4e7501eb-74e6-4ae7-8a18-04c13b6f5ddc", "evidence": "The deck outlines AstraZeneca's growth strategy and supporting data.", "position": 0, "objective": "How AstraZeneca's growth strategy will drive growth through 2030", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "aadac6c5-85ff-4c00-8a67-6ccfa3236c41", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "The deck showcases AstraZeneca's successes in various disease areas, including oncology and rare disease.", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "key_messages", "function": "size_opportunity", "notes": "Includes specific drug names and market projections for 2028.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/9", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-9", "loopMatches": [ { "to": 9, "from": 4, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "4e7501eb-74e6-4ae7-8a18-04c13b6f5ddc", "evidence": "The deck outlines AstraZeneca's growth strategy and supporting data.", "position": 0, "objective": "How AstraZeneca's growth strategy will drive growth through 2030", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "aadac6c5-85ff-4c00-8a67-6ccfa3236c41", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "The deck showcases AstraZeneca's successes in various disease areas, including oncology and rare disease.", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "section_divider", "function": "transition", "notes": "The slide features a scientific illustration of cellular interaction on the left and the business unit name with icons on the right.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/10", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "aadac6c5-85ff-4c00-8a67-6ccfa3236c41", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "The deck showcases AstraZeneca's successes in various disease areas, including oncology and rare disease.", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a three-column layout to categorize business units and their respective growth drivers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/11", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "aadac6c5-85ff-4c00-8a67-6ccfa3236c41", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "The deck showcases AstraZeneca's successes in various disease areas, including oncology and rare disease.", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "key_messages", "function": "size_opportunity", "notes": "NME stands for New Molecular Entity. FDC stands for Fixed-Dose Combination.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/12", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "aadac6c5-85ff-4c00-8a67-6ccfa3236c41", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "The deck showcases AstraZeneca's successes in various disease areas, including oncology and rare disease.", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "key_messages", "function": "summarize", "notes": "Includes clinical development pipeline visualization and market growth projections.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/13", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "aadac6c5-85ff-4c00-8a67-6ccfa3236c41", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "The deck showcases AstraZeneca's successes in various disease areas, including oncology and rare disease.", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "key_messages", "function": "quantify_opportunity", "notes": "Includes a table comparing hospitalization rates for RSV, hMPV, and Influenza across age groups.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/14", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "aadac6c5-85ff-4c00-8a67-6ccfa3236c41", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "The deck showcases AstraZeneca's successes in various disease areas, including oncology and rare disease.", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/15", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-15", "loopMatches": [ { "to": 17, "from": 15, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "328d8b39-68a9-4a4f-8944-dc6948d92940", "evidence": "The deck highlights the potential benefits of AstraZeneca's pipeline and growth strategy.", "position": 1, "objective": "The cost of not investing in AstraZeneca's pipeline and growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 17, "from": 15, "beatId": "f8397b24-3413-4fd3-a720-393bac88f957", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "The Breakthrough", "beatSlug": "rags-to-riches-the-breakthrough", "evidence": "The deck highlights AstraZeneca's pipeline momentum and growth potential.", "position": 3, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "key_takeaways", "function": "size_opportunity", "notes": "The slide uses a waterfall-style growth diagram for Ultomiris and a combination of bar charts and bulleted metrics for HPP assets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/16", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-16", "loopMatches": [ { "to": 17, "from": 15, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "328d8b39-68a9-4a4f-8944-dc6948d92940", "evidence": "The deck highlights the potential benefits of AstraZeneca's pipeline and growth strategy.", "position": 1, "objective": "The cost of not investing in AstraZeneca's pipeline and growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 17, "from": 15, "beatId": "f8397b24-3413-4fd3-a720-393bac88f957", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "The Breakthrough", "beatSlug": "rags-to-riches-the-breakthrough", "evidence": "The deck highlights AstraZeneca's pipeline momentum and growth potential.", "position": 3, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "key_messages", "function": "present_solution", "notes": "The slide uses a split layout: left side details specific drug assets (anselamimab, ALXN2220) with clinical stage data, right side outlines the genomic medicine strategy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/17", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-17", "loopMatches": [ { "to": 17, "from": 15, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "328d8b39-68a9-4a4f-8944-dc6948d92940", "evidence": "The deck highlights the potential benefits of AstraZeneca's pipeline and growth strategy.", "position": 1, "objective": "The cost of not investing in AstraZeneca's pipeline and growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 17, "from": 15, "beatId": "f8397b24-3413-4fd3-a720-393bac88f957", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "The Breakthrough", "beatSlug": "rags-to-riches-the-breakthrough", "evidence": "The deck highlights AstraZeneca's pipeline momentum and growth potential.", "position": 3, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/18", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 18, "beatId": "3cef57b3-4ceb-43aa-be90-d631b3225e75", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "The deck concludes with a strong call to action, emphasizing AstraZeneca's unique investment opportunity.", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide highlights both internal R&D focus areas and external acquisitions (Cellectis, Quell, Gracell) to support long-term growth.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/19", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 18, "beatId": "3cef57b3-4ceb-43aa-be90-d631b3225e75", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "The deck concludes with a strong call to action, emphasizing AstraZeneca's unique investment opportunity.", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "key_messages", "function": "summarize", "notes": "Includes specific targets for 2025, 2026, and 2030.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/20", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 18, "beatId": "3cef57b3-4ceb-43aa-be90-d631b3225e75", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "The deck concludes with a strong call to action, emphasizing AstraZeneca's unique investment opportunity.", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a four-column layout to highlight key strategic pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/21", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 18, "beatId": "3cef57b3-4ceb-43aa-be90-d631b3225e75", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "The deck concludes with a strong call to action, emphasizing AstraZeneca's unique investment opportunity.", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/22", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/23", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/24", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/25", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-91e2-76fd-b3d2-f30dde172711", "docSlug": "0239a71f9c69421092604a0a694fdb09", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/26", "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711", "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-928b-754c-8bda-49c7fed3154d", "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227", "documentTitle": "ATAI | Investor Presentation Deck | 34 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "Includes company logo, mission statement, and date.", "imagePath": "https://imgproxy.kitesheet.com/yzO2ZGhEQi0EWdYpIRGNu9jRYMylI413yuS9PV6auTw/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81OGE4ZjgzMGQzYzlmOWE2ZmVkZDY0YTBkMmExMDIyNy9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/1", "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d", "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/RPzzazLGLu4u9h0S4yXLZIntvCE1wQD_5-QXV6kR1JU/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81OGE4ZjgzMGQzYzlmOWE2ZmVkZDY0YTBkMmExMDIyNy9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/h2Pfp9DJax1oQLAnB2mTaXRPMUvSSMM_s_JAz8XuY3o/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81OGE4ZjgzMGQzYzlmOWE2ZmVkZDY0YTBkMmExMDIyNy9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/A1cMU5palp2RS3tShRjJGxZ7yVkwMoODRqlbB4so0iA/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81OGE4ZjgzMGQzYzlmOWE2ZmVkZDY0YTBkMmExMDIyNy9wMDAxLnBuZw" }, { "docId": "019de076-928b-754c-8bda-49c7fed3154d", "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227", "documentTitle": "ATAI | Investor Presentation Deck | 34 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": "Page number 02 in top right corner.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/2", "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d", "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-928b-754c-8bda-49c7fed3154d", "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227", "documentTitle": "ATAI | Investor Presentation Deck | 34 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": "Slide 03 of the deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/3", "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d", "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-3", "loopMatches": [ { "to": 34, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf", "evidence": "The deck emphasizes the need for effective treatments", "position": 0, "objective": "Highlight the importance of addressing mental health disorders", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 34, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5", "evidence": "The deck follows a structure that aligns with the Golden Circle", "position": 1, "objective": "Explain the company's approach and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 4, "from": 3, "beatId": "c46ef448-6306-4f67-92f6-ae26d067cb44", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The executive summary and roadmap slides outline the problem and the company's approach", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-928b-754c-8bda-49c7fed3154d", "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227", "documentTitle": "ATAI | Investor Presentation Deck | 34 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style visualization to show drug development progress across Preclinical, Phase 1, Phase 2, and Phase 3 stages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/4", "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d", "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-4", "loopMatches": [ { "to": 34, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf", "evidence": "The deck emphasizes the need for effective treatments", "position": 0, "objective": "Highlight the importance of addressing mental health disorders", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 34, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5", "evidence": "The deck follows a structure that aligns with the Golden Circle", "position": 1, "objective": "Explain the company's approach and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 4, "from": 3, "beatId": "c46ef448-6306-4f67-92f6-ae26d067cb44", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The executive summary and roadmap slides outline the problem and the company's approach", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 5, "from": 4, "beatId": "d35cc5e5-8cdb-4d34-a291-6e8a43f20fd6", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Roadmap", "beatSlug": null, "evidence": "The roadmap slides outline the expected milestones and timeline", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-928b-754c-8bda-49c7fed3154d", "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227", "documentTitle": "ATAI | Investor Presentation Deck | 34 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a table-like structure to track progress (checkmarks for completed, squares for upcoming) across 8 distinct drug programs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/5", "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d", "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-5", "loopMatches": [ { "to": 34, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf", "evidence": "The deck emphasizes the need for effective treatments", "position": 0, "objective": "Highlight the importance of addressing mental health disorders", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 34, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5", "evidence": "The deck follows a structure that aligns with the Golden Circle", "position": 1, "objective": "Explain the company's approach and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 16, "from": 5, "beatId": "09704901-0616-4280-b246-1ed7c74e3475", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The solution is presented through various product overviews and clinical evidence sections", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 5, "from": 4, "beatId": "d35cc5e5-8cdb-4d34-a291-6e8a43f20fd6", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Roadmap", "beatSlug": null, "evidence": "The roadmap slides outline the expected milestones and timeline", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-928b-754c-8bda-49c7fed3154d", "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227", "documentTitle": "ATAI | Investor Presentation Deck | 34 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "section_divider", "function": "transition", "notes": "The slide uses a blue-tinted portrait to evoke a clinical or therapeutic context.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/6", "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d", "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-6", "loopMatches": [ { "to": 34, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf", "evidence": "The deck emphasizes the need for effective treatments", "position": 0, "objective": "Highlight the importance of addressing mental health disorders", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 34, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5", "evidence": "The deck follows a structure that aligns with the Golden Circle", "position": 1, "objective": "Explain the company's approach and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 16, "from": 5, "beatId": "09704901-0616-4280-b246-1ed7c74e3475", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The solution is presented through various product overviews and clinical evidence sections", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-928b-754c-8bda-49c7fed3154d", "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227", "documentTitle": "ATAI | Investor Presentation Deck | 34 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "traction", "function": "show_traction", "notes": "Includes two line charts showing PK and PD profiles across different dosage levels.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/7", "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d", "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-7", "loopMatches": [ { "to": 34, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf", "evidence": "The deck emphasizes the need for effective treatments", "position": 0, "objective": "Highlight the importance of addressing mental health disorders", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 34, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5", "evidence": "The deck follows a structure that aligns with the Golden Circle", "position": 1, "objective": "Explain the company's approach and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 16, "from": 5, "beatId": "09704901-0616-4280-b246-1ed7c74e3475", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The solution is presented through various product overviews and clinical evidence sections", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 13, "from": 7, "beatId": "13d3fbaf-8feb-4114-88c3-3adfe518ba85", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The traction slides showcase the results from completed studies and clinical evidence", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-928b-754c-8bda-49c7fed3154d", "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227", "documentTitle": "ATAI | Investor Presentation Deck | 34 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "The slide outlines a 12-week open-label study with a specific focus on treatment-resistant depression (TRD).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/8", "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d", "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-8", "loopMatches": [ { "to": 34, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf", "evidence": "The deck emphasizes the need for effective treatments", "position": 0, "objective": "Highlight the importance of addressing mental health disorders", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 34, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5", "evidence": "The deck follows a structure that aligns with the Golden Circle", "position": 1, "objective": "Explain the company's approach and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 16, "from": 5, "beatId": "09704901-0616-4280-b246-1ed7c74e3475", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The solution is presented through various product overviews and clinical evidence sections", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 13, "from": 7, "beatId": "13d3fbaf-8feb-4114-88c3-3adfe518ba85", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The traction slides showcase the results from completed studies and clinical evidence", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-928b-754c-8bda-49c7fed3154d", "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227", "documentTitle": "ATAI | Investor Presentation Deck | 34 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "The slide uses a timeline-based process diagram to illustrate the clinical trial flow.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/9", "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d", "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-9", "loopMatches": [ { "to": 34, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf", "evidence": "The deck emphasizes the need for effective treatments", "position": 0, "objective": "Highlight the importance of addressing mental health disorders", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 34, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5", "evidence": "The deck follows a structure that aligns with the Golden Circle", "position": 1, "objective": "Explain the company's approach and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 16, "from": 5, "beatId": "09704901-0616-4280-b246-1ed7c74e3475", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The solution is presented through various product overviews and clinical evidence sections", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 13, "from": 7, "beatId": "13d3fbaf-8feb-4114-88c3-3adfe518ba85", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The traction slides showcase the results from completed studies and clinical evidence", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-928b-754c-8bda-49c7fed3154d", "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227", "documentTitle": "ATAI | Investor Presentation Deck | 34 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "section_divider", "function": "transition", "notes": "The slide features a stylized portrait of a person, likely a patient or representative, within a circular frame.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/10", "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d", "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-10", "loopMatches": [ { "to": 34, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf", "evidence": "The deck emphasizes the need for effective treatments", "position": 0, "objective": "Highlight the importance of addressing mental health disorders", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 34, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5", "evidence": "The deck follows a structure that aligns with the Golden Circle", "position": 1, "objective": "Explain the company's approach and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 16, "from": 5, "beatId": "09704901-0616-4280-b246-1ed7c74e3475", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The solution is presented through various product overviews and clinical evidence sections", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 13, "from": 7, "beatId": "13d3fbaf-8feb-4114-88c3-3adfe518ba85", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The traction slides showcase the results from completed studies and clinical evidence", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-928b-754c-8bda-49c7fed3154d", "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227", "documentTitle": "ATAI | Investor Presentation Deck | 34 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "solution", "function": "present_solution", "notes": "Includes a map of global disease burden and key product features.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/11", "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d", "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-11", "loopMatches": [ { "to": 34, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf", "evidence": "The deck emphasizes the need for effective treatments", "position": 0, "objective": "Highlight the importance of addressing mental health disorders", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 34, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5", "evidence": "The deck follows a structure that aligns with the Golden Circle", "position": 1, "objective": "Explain the company's approach and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 16, "from": 5, "beatId": "09704901-0616-4280-b246-1ed7c74e3475", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The solution is presented through various product overviews and clinical evidence sections", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 13, "from": 7, "beatId": "13d3fbaf-8feb-4114-88c3-3adfe518ba85", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The traction slides showcase the results from completed studies and clinical evidence", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-928b-754c-8bda-49c7fed3154d", "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227", "documentTitle": "ATAI | Investor Presentation Deck | 34 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "traction", "function": "show_traction", "notes": "The slide cites a third-party study (Palhano-Fontes et al.) as proxy evidence for DMT efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/12", "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d", "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-12", "loopMatches": [ { "to": 34, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf", "evidence": "The deck emphasizes the need for effective treatments", "position": 0, "objective": "Highlight the importance of addressing mental health disorders", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 34, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5", "evidence": "The deck follows a structure that aligns with the Golden Circle", "position": 1, "objective": "Explain the company's approach and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 16, "from": 5, "beatId": "09704901-0616-4280-b246-1ed7c74e3475", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The solution is presented through various product overviews and clinical evidence sections", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 13, "from": 7, "beatId": "13d3fbaf-8feb-4114-88c3-3adfe518ba85", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The traction slides showcase the results from completed studies and clinical evidence", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-928b-754c-8bda-49c7fed3154d", "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227", "documentTitle": "ATAI | Investor Presentation Deck | 34 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a process flow diagram to show the progression of the trial parts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/13", "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d", "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-13", "loopMatches": [ { "to": 34, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf", "evidence": "The deck emphasizes the need for effective treatments", "position": 0, "objective": "Highlight the importance of addressing mental health disorders", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 34, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5", "evidence": "The deck follows a structure that aligns with the Golden Circle", "position": 1, "objective": "Explain the company's approach and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 16, "from": 5, "beatId": "09704901-0616-4280-b246-1ed7c74e3475", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The solution is presented through various product overviews and clinical evidence sections", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 13, "from": 7, "beatId": "13d3fbaf-8feb-4114-88c3-3adfe518ba85", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The traction slides showcase the results from completed studies and clinical evidence", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-928b-754c-8bda-49c7fed3154d", "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227", "documentTitle": "ATAI | Investor Presentation Deck | 34 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a minimalist design with a focus on the product name and target indications, accompanied by a human-centric image.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/14", "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d", "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-14", "loopMatches": [ { "to": 34, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf", "evidence": "The deck emphasizes the need for effective treatments", "position": 0, "objective": "Highlight the importance of addressing mental health disorders", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 34, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5", "evidence": "The deck follows a structure that aligns with the Golden Circle", "position": 1, "objective": "Explain the company's approach and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 16, "from": 5, "beatId": "09704901-0616-4280-b246-1ed7c74e3475", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The solution is presented through various product overviews and clinical evidence sections", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-928b-754c-8bda-49c7fed3154d", "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227", "documentTitle": "ATAI | Investor Presentation Deck | 34 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a line chart to show the change in MADRS scores over 12 weeks for three different dosages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/15", "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d", "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-15", "loopMatches": [ { "to": 34, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf", "evidence": "The deck emphasizes the need for effective treatments", "position": 0, "objective": "Highlight the importance of addressing mental health disorders", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 34, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5", "evidence": "The deck follows a structure that aligns with the Golden Circle", "position": 1, "objective": "Explain the company's approach and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 16, "from": 5, "beatId": "09704901-0616-4280-b246-1ed7c74e3475", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The solution is presented through various product overviews and clinical evidence sections", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }